CoChat

Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications

Haroon, Ebrahim, Miller, Andrew H. · 2016 · Current Topics in Behavioral Neurosciences

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Abstract

There has been increasing interest in the role of glutamate in mood disorders, especially given the profound effect of the glutamate receptor antagonist ketamine in improving depressive symptoms in patients with treatment-resistant depression. One pathway by which glutamate alterations may occur in mood disorders involves inflammation. Increased inflammation has been observed in a significant subgroup of patients with mood disorders, and inflammatory cytokines have been shown to influence glutamate metabolism through effects on astrocytes and microglia. In addition, the administration of the inflammatory cytokine interferon-alpha has been shown to increase brain glutamate in the basal ganglia and dorsal anterior cingulate cortex as measured by magnetic resonance spectroscopy (MRS). Moreover, MRS studies in patients with major depressive disorder have revealed that increased markers of inflammation including C-reactive protein correlate with increased basal ganglia glutamate, which in turn was associated with anhedonia and psychomotor retardation. Finally, human and laboratory animal studies have shown that the response to glutamate antagonists such as ketamine is predicted by increased inflammatory cytokines. Taken together, these data make a strong case that inflammation may influence glutamate metabolism to alter behavior, leading to depressive symptoms including anhedonia and psychomotor slowing.

Overview

Integrity signals

Registry

Crossref · 10.1007/7854_2016_40

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 137 references

Research works printed but not linked: 2

  1. CDC (2015) Suicide - facts at a glance 2015. Centers for Disease Control, Atlanta, GA, USA
  2. Hashemian F, Majd M, Hosseini SM, Sharifi A, Panahi MVS, Bigdeli O (2011) A randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in the treatment of a drug-naive women with major depression. Klinik Psikofarmakoloji Bulteni 21:S183–S184

Cited by

Metadata

Authors
Haroon, E., & Miller, A. H.
Affiliations
Emory University (US)
Corresponding author
Miller, Andrew H.
Venue
Current Topics in Behavioral Neurosciences
Published
2016
Volume
31
Pages
173-198
ISSN
  • 1866-3370 (ISSN-L)
  • 1866-3389
OpenAlex
W2552532188
Cited by
153
References
137
Citations by year
2026: 6 · 2025: 16 · 2024: 18 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 5 · 2016: 2
FWCI
2.77
Type
book chapter
Language
en
Open access
closed
Locations
  • Current topics in behavioral neurosciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000454)
  • National Institute of Mental Health (R21MH077172, R01MH112076, R03MH100273, R01MH107033, R01MH087604, K23MH091254, R21MH105897)
  • National Cancer Institute (P30CA138292)
  • National Center for Research Resources (UL1RR025008)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
brain glutamate, inflammation, depression, major depressive disorder, inflammatory cytokines, ketamine, treatment-resistant depression, astrocytes, microglia, interferon-alpha, C-reactive protein, basal ganglia, dorsal anterior cingulate cortex, anhedonia, psychomotor retardation, glutamate metabolism
MeSH terms
Animals, Depression, Humans, Inflammation, Excitatory Amino Acid Antagonists, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.